Association between a variant of the sigma-1 receptor gene and Alzheimer's disease

被引:64
作者
Feher, Agnes [1 ]
Juhasz, Anna [1 ]
Laszlo, Anna [2 ]
Kalman, Janos, Jr. [1 ]
Pakaski, Magdolna [1 ]
Kalman, Janos [1 ]
Janka, Zoltan [1 ]
机构
[1] Univ Szeged, Dept Psychiat, H-6724 Szeged, Hungary
[2] Univ Szeged, Dept Med Phys & Informat, H-6724 Szeged, Hungary
关键词
Alzheimer's disease; Sigma non-opioid intracellular receptor 1 (SIGMAR1); Single nucleotide polymorphism (SNP); rs1799729; rs1800866; Apolipoprotein E4; INDUCED TOXICITY; TYPE-1; GENE; SIGMA(1)-RECEPTOR; POLYMORPHISMS; BRAIN; MICE;
D O I
10.1016/j.neulet.2012.04.046
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with complex etiology and strong genetic predisposition. A number of investigations support the possible involvement of sigma non-opioid intracellular receptor 1 (SIGMAR1) in the pathophysiology of AD. We aimed to investigate the association between SIGMAR1 polymorphisms and late-onset AD, therefore we genotyped rs1799729 (GC-241-240TT) and rs1800866 (Q2P) in 322 Hungarian late-onset AD patients and 250 ethnically matched, elderly control individuals. The investigated polymorphisms were in nearly complete linkage disequilibrium resulting in the GC-Q and TT-P predominant haplotypes that were subjected to the statistical analyses. Our data demonstrates an association between the SIGMAR1 TT-P variant and the risk for developing AD (p = 0.019), and a potential modest interaction effect (p = 0.058) of the co-presence of the TT-P haplotype with apolipoprotein E4 allele on the risk for AD. Based on this mild significance, we could not fully support the hypothesis that TT-P haplotype in interaction with APOE E4 allele confers risk for developing AD. (C) 2012 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:136 / 139
页数:4
相关论文
共 21 条
[1]  
[Anonymous], STAT POWER ANAL BEHA
[2]   Genetics of Alzheimer Disease [J].
Bekris, Lynn M. ;
Yu, Chang-En ;
Bird, Thomas D. ;
Tsuang, Debby W. .
JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2010, 23 (04) :213-227
[3]   Focus on molecules: the sigma-1 receptor [J].
Duncan, G ;
Wang, LX .
EXPERIMENTAL EYE RESEARCH, 2005, 81 (02) :121-122
[4]   No association between CALHM1 polymorphism and Alzheimer's disease risk in a Hungarian population [J].
Feher, Agnes ;
Juhasz, Anna ;
Rimanoczy, Agnes ;
Pakaski, Magdolna ;
Kalman, Janos ;
Janka, Zoltan .
PSYCHIATRIC GENETICS, 2011, 21 (05) :249-252
[5]  
Hayashi T, 2000, J PHARMACOL EXP THER, V293, P788
[6]   Association between polymorphisms in the type 1 sigma receptor gene and schizophrenia [J].
Ishiguro, H ;
Ohtsuki, T ;
Toru, M ;
Itokawa, M ;
Aoki, J ;
Shibuya, H ;
Kurumaji, A ;
Okubo, Y ;
Iwawaki, A ;
Ota, K ;
Shimizu, H ;
Hamaguchi, H ;
Arinami, T .
NEUROSCIENCE LETTERS, 1998, 257 (01) :45-48
[7]  
Ishii K, 2002, NEUROIMAGE, V16, pS31
[8]   LOSS OF SIGMA-BINDING SITES IN THE CA1 AREA OF THE ANTERIOR HIPPOCAMPUS IN ALZHEIMERS-DISEASE CORRELATES WITH CA1 PYRAMIDAL CELL LOSS [J].
JANSEN, KLR ;
FAULL, RLM ;
STOREY, P ;
LESLIE, RA .
BRAIN RESEARCH, 1993, 623 (02) :299-302
[9]   An increase of sigma1 receptors in the aged monkey brain [J].
Kawamura, K ;
Kimura, Y ;
Tsukada, H ;
Kobayashi, T ;
Nishiyama, S ;
Kakiuchi, T ;
Ohba, H ;
Harada, N ;
Matsuno, K ;
Ishii, K ;
Ishiwata, K .
NEUROBIOLOGY OF AGING, 2003, 24 (05) :745-752
[10]   Association analysis of SIGMAR1 with major depressive disorder and SSRI response [J].
Kishi, Taro ;
Yoshimura, Reiji ;
Okochi, Tomo ;
Fukuo, Yasuhisa ;
Kitajima, Tsuyoshi ;
Okumura, Takenori ;
Tsunoka, Tomoko ;
Kawashima, Kunihiro ;
Yamanouchi, Yoshio ;
Kinoshita, Yoko ;
Umene-Nakano, Wakako ;
Naitoh, Hiroshi ;
Nakamura, Jun ;
Ozaki, Norio ;
Iwata, Nakao .
NEUROPHARMACOLOGY, 2010, 58 (07) :1168-1173